S.I. Petrenko

S.I. Petrenko

Auto-generated profile, based on publicly available information

S.I. Petrenko

Moscow State University of Medicine and Dentistry

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2023 in Russian Journal of Evidence-Based Gastroenterology
Verified
Journal Article
Closed access
SDS.A. Domrachev
S.A. Domrachev
NSN.O. Solovyev
N.O. Solovyev
SPS.I. Petrenko
S.I. Petrenko
PTP.S. Tyutyunnik
P.S. Tyutyunnik
VTV.G. Tsyplenkova
V.G. Tsyplenkova
Esophageal cancer ranks 8th in incidence and 6th in mortality among oncological diseases in the world. To date, interest in the analysis of oncological patients’ quality of life is steadily growing. The majority of the questionnaires for evaluating patients quality of life with esophageal cancer, however, have not been validated and translated into Russian. Objective. To study the world’s experience of using patient-reported outcome measures (PROMs) that assess the quality of life in patients with esophageal cancer. Key points. We examined the most popular PROMs for esophageal cancer patients. The techniques and potential applications of these questionnaires throughout different stages of treatment in clinical settings, along with the influence of esophageal cancer treatment on quality of life, were explored. Conclusions. While evaluating outcomes and contrasting diverse treatment approaches, it is crucial to consider not only clinical data but also the subjective evaluations made by patients regarding their quality of life. Modern PROMs not only provide a comprehensive assessment of patients’ quality of life but also facilitate comparisons between different treatment modalities, including those for esophageal cancer patients. Clearly, there is a requirement to customize and validate the existing pertinent quality of life questionnaires for individuals with esophageal cancer in the context of Russia.

23 April 2023 in Russian Journal of Evidence-Based Gastroenterology
Verified
Journal Article
Closed access
VAV.D. Anosov
V.D. Anosov
SDS.A. Domrachev
S.A. Domrachev
SOS.V. Ovchinnikov
S.V. Ovchinnikov
NSN.O. Solovyev
N.O. Solovyev
POPolivoda
Polivoda
SPS.I. Petrenko
S.I. Petrenko
Objective. To assess the preventive role of arterial embolization in gastrointestinal bleeding (GIB), investigate its indications, and evaluate its effectiveness. Key points. The study involved an analysis of global experiences with prophylactic transarterial embolization for GIB. The suitability and efficiency of this approach for high-risk GIB recurrence patients were evaluated. Conclusions. Prophylactic transarterial embolization is an efficacious strategy for GIB prevention, as substantiated by randomized controlled trials and meta-analyses. However, more research is warranted to establish universal indications and guidelines for implementing prophylactic transarterial embolization in GIB cases.